U.S. drugmakers and biotechs have come to rely on Chinese partners. Now, some of them are looking for alternatives as geopolitical tensions rise.
Trending
- De Deense glamour van ROTATE
- Supreme Court rules in lenders’ favour in car finance case – in blow to motorists | Money News
- Trump fires official overseeing jobs data after dismal employment numbers | Donald Trump News
- Trump fires lead official on economic data as tariffs cause market drop
- Inside the Spanish region leading the way on climate adaptation
- Why Trump’s Tariffs Are Closing Factories in Lesotho
- Tech companies are racing to make their products smaller – and much, much thinner | Money News
- Chess grandmaster Magnus Carlsen wins at Esports World Cup
